Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-04

Clinical Trial Update: Pain Relief From Dysmenorrhea Employing taVNS [NA]

View source ↗

Summary

A clinical trial is investigating whether transcutaneous auricular vagus nerve stimulation (taVNS) can relieve pain in dysmenorrhea and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous auricular vagus nerve stimulation (taVNS) (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: University of Electronic Science and Technology of China | Conditions: Dysmenorrhea Primary | NA | Status: RECRUITING